Effectiveness of premedication and rapid desensitization in hypersensitivity to L-asparaginase
Allergy, Asthma & Respiratory Disease
;
: 288-293, 2015.
Artículo
en Coreano
| WPRIM
| ID: wpr-83769
ABSTRACT
PURPOSE:
L-asparaginase is a crucial chemotherapeutic agent for the treatment of acute lymphoblastic leukemia. However, hypersensitivity to L-asparaginase is common which limits its clinical use.METHODS:
We performed 44 cases of premedication and 3 cases of desensitization in 16 patients with hypersensitivity to L-asparaginase.RESULTS:
With premedication, 33 cases completed L-asparaginase injection with no hypersensitivity reactions. Eleven cases showed mild hypersensitivity reactions, such as urticaria. Desensitization was performed in 3 cases in 2 cases, desensitization was successful, and in 1 case the medication was switched to Erwinia asparaginase.CONCLUSION:
Premedication and desensitization appear to be useful in helping patients receive desired doses of L-asparaginase in pediatric patients with acute lymphoblastic leukemia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Premedicación
/
Asparaginasa
/
Urticaria
/
Desensibilización Inmunológica
/
Hipersensibilidad a las Drogas
/
Erwinia
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Hipersensibilidad
Límite:
Humanos
Idioma:
Coreano
Revista:
Allergy, Asthma & Respiratory Disease
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS